What is the SRT-100 Treatment?

Elias Dermatology® provides state-of-the-art skin cancer and keloid treatments. Patients looking for alternative skin cancer and keloid treatments can visit their offices in Ft. Lauderdale and Pembroke Pines, Florida. The Superficial Radiation Therapy (SRT) system is ideal for basal cell carcinoma treatment and squamous cell carcinoma treatment. This compact, state-of-the-art system executes an exact amount of SRT that penetrates only five millimeters below the skin’s surface. The SRT-100 carefully destroys malignant skin cancer cells while protecting healthy tissue. This mobile unit is one of the safest and most effective cancer treatments available.

 

What are the benefits of the SRT-100?

What are the benefits of the SRT-100?The SRT-100 is a non-surgical option to Mohs surgery. Even though Mohs surgery has been the first choice for basal cell carcinoma treatment and squamous cell carcinoma treatment, it has several potential drawbacks. The removal of cancerous tissue along with healthy surrounding tissue causes a painful and lengthy recovery process that increases the risk of infection and scarring. There are no post-surgical infections or complications with the SRT-100. It provides patients and physicians with a safe and effective treatment option. Some of the benefits of the SRT-100 are:

  • Excellent cure rates that compete against surgery

  • No lifestyle restrictions

  • Quick treatment sessions

  • No anesthesia, cutting, bleeding, stitching or pain

  • No unsightly scarring

  • No need for post-treatment reconstructive surgeries

 

Is SRT an effective keloid treatment?

Keloid scars are shiny, fibrous nodules triggered by too much collagen production and an overgrowth of scar tissue that can be painful and unsightly. Preventing keloid scars is tough to do because of the genetic predisposition in African American, Asian, Hispanic and skin of color individuals. There are topical over-the-counter products for Keloid removal but they aren’t very effective. Keloid treatment usually requires surgery but there is a high risk that the incision made during the keloid removal will become the site of a new keloid. The SRT-100 has a high success rate with keloid treatment. A low dose of Superficial Radiation Therapy after surgical keloid removal prevents the regrowth of a new keloid. 

Frequently Asked Questions About SRT-100

What kind of conditions can be treated with the SRT-100™?

The SRT-100™ treats the following conditions: Squamous cell carcinoma Basal cell carcinoma Metatypical carcinoma Keloid scars Actinic keratosis Kaposi’s sarcoma Cutaneous appendage carcinoma

How effective is the SRT-100™ at treating basal and squamous cell skin cancer?

Comparable to surgery, the cure rate of basal and squamous cell skin cancer is 95% when treated with the SRT-100™.

How effective is the SRT-100™  at treating Keloids?

The SRT-100™ is 90% effective in treating Keloids.

How long is a typical SRT-100™ treatment?

Treatments are short and last less than a minute. Some cases require several treatments per week for up to several weeks, depending on the treatment plan your physician will customize for you.

Is the SRT-100™ a safe option for cancer treatment?

The SRT-100™ is used by dermatologists and radiation oncologists globally as an effective, safe, and proven option for treating non-melanoma skin cancers, Keloids, actinic keratosis, and Kaposi’s sarcoma.

What are the benefits of SRT-100™ treatment?

The SRT-100™ is an excellent alternative to surgery because it targets cancer cells without posing harm to the surrounding or underlying tissue. Additional benefits include:

  • No cutting

  • No pain

  • No bleeding

  • No anesthesia

  • No stitching

  • No scarring

  • No interruption of lifestyle

  • No reconstructive surgery

What can I expect post-treatment from the SRT-100™?

Since the SRT-100™ is non-invasive, patients do not need to worry about any post-treatment scarring that may require surgery.

Is the SRT-100™ FDA approved?

The SRT-100™ is approved by the Federal Drug Administration for use on the entire body.